Biomarkers for intestinal damage in pediatric celiac disease
Frontiers in Pediatrics · 29.10.2026 · 14
DOI: 10.3389/fped.2026.2000459 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pediatrics, online erschienen am 29.10.2026. Verfasst von Kamola Sh Usmonova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Republican Specialized Scientific-Practical Medical Center of Pediatrics, Tashkent, Uzbekistan. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Celiac disease (CD) is an immune-mediated enteropathy triggered by gluten in genetically predisposed individuals, affecting around 1% of the global population. Diagnosis relies on serological testing (IgA antibodies to transglutaminase 2 and endomysium), supported by HLA-DQ2/DQ8 typing and duodenal biopsy when indicated. This approach has limitations, including false negatives in IgA deficiency, poor sensitivity in potential or minimal-lesion CD, poor correlation with mucosal healing, and limited ability to predict disease progression. This mini review summarizes non-invasive and minimally invasive biomarkers for the diagnosis and follow-up of CD, with special attention to the pediatric setting. We discuss markers of enterocyte injury (intestinal fatty acid-binding protein, i-FABP; citrulline), immune activation (cytokines, high-mobility group box 1), gluten exposure and barrier function (fecal and urinary gluten immunogenic peptides, zonulin, calprotectin), and molecular signatures emerging from microbiome and multi-omics research. Of these, i-FABP (for diagnosis and follow-up) and gluten immunogenic peptides (for monitoring adherence to a gluten-free diet) appear the most promising. However, assay standardization, age-specific reference ranges, and large-scale prospective pediatric validation remain necessary before routine implementation, and data from regions such as Central Asia are scarce.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Republican Specialized Scientific-Practical Medical Center of Pediatrics, Tashkent, Uzbekistan.
Zitieren
APA
Sh Usmonova, K., Geller, S. I., Umarnazarova, Z. E., & Kamilova, A. T. (2026). Biomarkers for intestinal damage in pediatric celiac disease. Frontiers in Pediatrics, 14. https://doi.org/10.3389/fped.2026.2000459
Vancouver
Sh Usmonova K, Geller SI, Umarnazarova ZE, Kamilova AT. Biomarkers for intestinal damage in pediatric celiac disease. Frontiers in Pediatrics. 2026;14. doi:10.3389/fped.2026.2000459
BibTeX
@article{ShUsmonova2026,
author = {Sh Usmonova, Kamola and Geller, Svetlana I and Umarnazarova, Zulhumor E and Kamilova, Altinoy T},
title = {Biomarkers for intestinal damage in pediatric celiac disease},
journal = {Frontiers in Pediatrics},
year = {2026},
volume = {14},
doi = {10.3389/fped.2026.2000459}
}
EUVIMED